El efecto pleiotrópico es primordial para el beneficio del tratamiento con estatinas (Agonista)
Barrios, Alceo.
Rev. argent. cardiol
; 75(1): 42-43, ene.-feb. 2007. graf
Artículo en Español | LILACS | ID: lil-476952
Documentos relacionados
Finding the Balance Between Benefits and Harms When Using Statins for Primary Prevention of Cardiovascular Disease: A Modeling Study.
Hair analysis as a new tool to monitor adherence to long-term therapy to statins.
Adverse drug reactions of statin therapy in China from 1989 to 2019: a national database analysis.
Doubly robust estimator of risk in the presence of censoring dependent on time-varying covariates: application to a primary prevention trial for coronary events with pravastatin.
Can statins reduce the inflammatory response associated with preterm birth in an animal model?
Statin therapy increases lipoprotein(a) levels.
Comparison and analysis of the therapeutic effect of different statins in the treatment of atherosclerosis.
A randomized pilot clinical trial of pravastatin versus placebo in pregnant patients at high risk of preeclampsia.
Drug effect of atorvastatin on middle cerebral atherosclerotic stenosis and high resolution NMR diagnosis.
Comparison of the efficacy and safety of pravastatin and simvastatin in heart transplantation.